190 related articles for article (PubMed ID: 8996763)
1. Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization.
al-Hemsi B; McGory RW; Shepard B; Ishitani MB; Stevenson WC; McCullough C; Pruett TL
Clin Transplant; 1996 Dec; 10(6 Pt 2):668-75. PubMed ID: 8996763
[TBL] [Abstract][Full Text] [Related]
2. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
[TBL] [Abstract][Full Text] [Related]
3. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.
Sawyer RG; McGory RW; Gaffey MJ; McCullough CC; Shephard BL; Houlgrave CW; Ryan TS; Kuhns M; McNamara A; Caldwell SH; Abdulkareem A; Pruett TL
Ann Surg; 1998 Jun; 227(6):841-50. PubMed ID: 9637547
[TBL] [Abstract][Full Text] [Related]
4. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft.
Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T; Terrault N; Roberts J; Ascher N; Wright T; Lake J
Transplantation; 1997 Aug; 64(3):410-4. PubMed ID: 9275104
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
Dodson SF; de Vera ME; Bonham CA; Geller DA; Rakela J; Fung JJ
Liver Transpl; 2000 Jul; 6(4):434-9. PubMed ID: 10915164
[TBL] [Abstract][Full Text] [Related]
7. Evolving experience of hepatitis B virus prophylaxis in liver transplantation.
Honaker MR; Shokouh-Amiri MH; Vera SR; Alloway RR; Grewal HP; Hardinger KL; Kizilisik AT; Bagous T; Trofe J; Stratta RJ; Egidi MF; Gaber AO
Transpl Infect Dis; 2002 Sep; 4(3):137-43. PubMed ID: 12421458
[TBL] [Abstract][Full Text] [Related]
8. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.
Angus PW; McCaughan GW; Gane EJ; Crawford DH; Harley H
Liver Transpl; 2000 Jul; 6(4):429-33. PubMed ID: 10915163
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens.
Anderson RD; Chinnakotla S; Guo L; Perrillo RP; Klintmalm GB; Davis GL
Clin Transplant; 2007; 21(4):510-7. PubMed ID: 17645711
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: effective prophylaxis against recurrence.
Powell JJ; Apiratpracha W; Partovi N; Erb SR; Scudamore CH; Steinbrecher UP; Buczkowski AK; Chung SW; Yoshida EM
Clin Transplant; 2006; 20(4):524-5. PubMed ID: 16842532
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation.
Nymann T; Shokouh-Amiri MH; Vera SR; Riely CA; Alloway RR; Gaber AO
Clin Transplant; 1996 Dec; 10(6 Pt 2):663-7. PubMed ID: 8996762
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B immune globulin: the US experience.
Pruett TL; McGory R
Clin Transplant; 2000; 14 Suppl 2():7-13. PubMed ID: 10965958
[TBL] [Abstract][Full Text] [Related]
14. Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression.
Gish RG; Keeffe EB; Lim J; Brooks LJ; Esquivel CO
J Hepatol; 1995 Mar; 22(3):257-62. PubMed ID: 7608474
[TBL] [Abstract][Full Text] [Related]
15. [A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].
Pei F; Zheng J; Du J; Zhong HH; Yang JP
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):408-14. PubMed ID: 18677390
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
Markowitz JS; Martin P; Conrad AJ; Markmann JF; Seu P; Yersiz H; Goss JA; Schmidt P; Pakrasi A; Artinian L; Murray NG; Imagawa DK; Holt C; Goldstein LI; Stribling R; Busuttil RW
Hepatology; 1998 Aug; 28(2):585-9. PubMed ID: 9696028
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.
Sánchez-Fueyo A; Rimola A; Grande L; Costa J; Mas A; Navasa M; Cirera I; Sánchez-Tapias JM; Rodés J
Hepatology; 2000 Feb; 31(2):496-501. PubMed ID: 10655276
[TBL] [Abstract][Full Text] [Related]
18. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
19. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.
McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; McCullough CS; Dickson RC; Caldwell SH; Pruett TL
Transplantation; 1996 May; 61(9):1358-64. PubMed ID: 8629297
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation.
Ku W; Wang U; Nguyen MH
Expert Opin Biol Ther; 2015 May; 15(5):665-77. PubMed ID: 25865452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
